Delivery Order SPE2DB22D1106-SPE2DB25FEVL1

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,779.20 fixed-price delivery order is for AZSTARYS CAPS 26.1MG/5.2MG, a pharmaceutical product, with a performance period ending on May 19, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a $1,797.13 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS 52.3 MG-10.4 MG CAP 100S, a pharmaceutical product, with a performance period ending on May 22, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,096.07, is a firm fixed-price delivery order for AZSTARYS CAPS 52.3MG/10.4MG. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a $1,304.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, with a performance period ending on February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,277.09, is for the provision of AZSTARYS CAPS 52.3MG/10.4MG, a pharmaceutical product. The award has an ultimate completion date of January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,284.14, is for the delivery of AZSTARYS CAPS 39.2MG/7.8MG, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 12, 2025. The contract has no set-aside designation, indicating open...
This is a $2,533.17 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AZSTARYS CAPS 39.2MG/7.8MG, a medical product, with a performance period ending on June 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The total ceiling value of the contract is $1,630.88, with a period of performance through June 11, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,017.85 and covers the delivery of the medication AZSTARYS 26.1 MG-5.2 MG CAP 100S. The contract is not set aside and has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price of $1,493.44 and an ultimate completion date of May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania and...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEVL1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.71 fixed-price delivery order is for the supply of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a pharmaceutical product, with a performance period ending on June 30, 2025.

The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/26/25, 10:02 AM